Form 4: HealthEquity Executive Reports Stock Sales Under Pre-Arranged 10b5-1 Plan

HealthEquity's EVP, Chief Commercial Officer, Michael Henry Fiore, reported the disposition of 1,636 shares for tax withholding and the sale of 1,794 common shares, all executed under a Rule 10b5-1 trading plan.

Summary

• Michael Henry Fiore, EVP, Chief Commercial Officer of HealthEquity, Inc. (HQY), reported changes in his beneficial ownership of common stock.
• On July 3, 2025, 1,636 shares were disposed of for tax withholding purposes at a price of $100.8721 per share.
• On July 7, 2025, 1,094 shares were sold at a weighted average price of $101.4972 per share, with prices ranging from $100.87 to $101.84.
• Also on July 7, 2025, an additional 700 shares were sold at a weighted average price of $102.0871 per share, with prices ranging from $101.94 to $102.26.
• All reported transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on December 18, 2024.
• Following these transactions, Michael Henry Fiore beneficially owns 53,225 shares of HealthEquity common stock.

Sentiment

Score: 5

Explanation: A Form 4 filing primarily reports insider transactions and does not inherently convey positive or negative sentiment about the company's performance or outlook. The transactions were conducted under a pre-arranged 10b5-1 plan, which is a neutral event for market sentiment.

Positives

• The transactions were conducted under a Rule 10b5-1 trading plan, which indicates pre-planned sales for personal financial management rather than sales based on new, non-public information, enhancing transparency.

Negatives

• The disposition and sale of shares by a key executive, even if pre-planned, reduces their direct ownership stake in the company.

Future Outlook

N/A

Industry Context

N/A

Related Party Transactions

• Michael Henry Fiore, EVP, Chief Commercial Officer, disposed of 1,636 shares for tax withholding and sold 1,794 shares of HealthEquity common stock.

Stakeholder Impact

• Shareholders: The sale of shares by a key executive, even under a Rule 10b5-1 plan, results in a slight reduction in insider ownership, which some investors may monitor. However, the pre-planned nature mitigates concerns about opportunistic selling.

Key Dates

Keywords

HealthEquity, HQY, SEC Form 4, Insider Trading, Stock Sale, Executive Compensation, Rule 10b5-1, Michael Henry Fiore, Common Stock